Institutional Ownership Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX). We have compiled data on the 197 institutions that hold shares in the stock, with a total of 69.7 Million shares, which have been reported (via 13F filing form) to have a value of $1.61 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Wellington Management Group LLP
Boston, MA |
Feb 12, 2025 Q4 2024 |
8,975,833
shares
|
$203 Million
0.04% of portfolio
|
Q4 2024
Reduced 2.9%
|
|
Kynam Capital Management, LP
Princeton, NJ |
Feb 14, 2025 Q4 2024 |
5,064,207
shares
|
$114 Million
8.11% of portfolio
|
Q4 2024
Added 46.42%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
4,690,761
shares
|
$106 Million
0.0% of portfolio
|
Q2 2024
Added 3.96%
|
|
Vanguard Group Inc
Valley Forge, PA |
Feb 11, 2025 Q4 2024 |
3,881,995
shares
|
$87.7 Million
0.0% of portfolio
|
Q4 2024
Added 0.32%
|
|
Eventide Asset Management, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
3,753,260
shares
|
$84.8 Million
1.82% of portfolio
|
Q4 2024
Added 12.64%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
3,557,136
shares
|
$80.4 Million
0.01% of portfolio
|
Q4 2024
Added 23.5%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
3,234,961
shares
|
$73.1 Million
0.0% of portfolio
|
Q4 2024
Added 30.17%
|
|
Bellevue Group Ag
Kuesnacht, V8 |
Feb 14, 2025 Q4 2024 |
3,071,615
shares
|
$69.4 Million
1.55% of portfolio
|
Q3 2024
Added 3.37%
|
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
Feb 14, 2025 Q4 2024 |
2,515,972
shares
|
$56.8 Million
0.15% of portfolio
|
Q4 2024
Added 60.38%
|
|
Jefferies Financial Group Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
2,390,398
shares
|
$54 Million
0.38% of portfolio
|
Q4 2024
Added 11282.85%
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
2,014,015
shares
|
$45.5 Million
0.38% of portfolio
|
Q4 2024
Reduced 13.97%
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
1,794,048
shares
|
$40.5 Million
0.07% of portfolio
|
Q2 2023
Added 130.12%
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,697,498
shares
|
$38.3 Million
0.03% of portfolio
|
Q4 2024
Reduced 2.13%
|
|
Polar Capital Holdings PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
1,565,831
shares
|
$35.4 Million
0.24% of portfolio
|
Q4 2024
Reduced 42.45%
|
|
Deep Track Capital, LP
Greenwich, CT |
Feb 14, 2025 Q4 2024 |
1,540,132
shares
|
$34.8 Million
1.71% of portfolio
|
Q4 2024
New holding
|
|
Geode Capital Management, LLC
Boston, MA |
Feb 12, 2025 Q4 2024 |
1,534,916
shares
|
$34.7 Million
0.0% of portfolio
|
Q4 2024
Reduced 0.36%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,344,099
shares
|
$30.4 Million
0.0% of portfolio
|
Q4 2024
Added 208.41%
|
|
Rock Springs Capital Management LP
Baltimore, MD |
Feb 14, 2025 Q4 2024 |
1,222,182
shares
|
$27.6 Million
1.23% of portfolio
|
Q4 2024
Added 10.73%
|
|
Goldman Sachs Group Inc
New York, NY |
Feb 11, 2025 Q4 2024 |
1,202,453
shares
|
$27.2 Million
0.0% of portfolio
|
Q4 2024
Reduced 34.5%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
Feb 12, 2025 Q4 2024 |
1,090,173
shares
|
$24.6 Million
0.03% of portfolio
|
Q4 2024
Reduced 4.24%
|
|
Novo Holdings
Hellerup, G7 |
Feb 14, 2025 Q4 2024 |
1,000,000
shares
|
$22.6 Million
2.05% of portfolio
|
Q4 2024
Added 3.77%
|
|
Eversept Partners, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
719,836
shares
|
$16.3 Million
1.84% of portfolio
|
Q4 2024
Added 27.43%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
708,086
shares
|
$16 Million
0.0% of portfolio
|
Q4 2024
Reduced 16.43%
|
|
Redmile Group, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
615,775
shares
|
$13.9 Million
1.22% of portfolio
|
Q4 2024
Reduced 6.3%
|
|
American Century Companies Inc
Kansas City, MO |
Feb 11, 2025 Q4 2024 |
608,457
shares
|
$13.7 Million
0.01% of portfolio
|
Q4 2024
Added 46.49%
|